NYSE International 100

NYSE International 100 handeln
10.642,80 PKT +48,69 PKT +0,46 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu NYSE International 100-Werten

Datum Rating Analyst
15.04.24 Nutrien (Ex Potash Agrium) Outperform RBC Capital Markets
15.04.24 ABB (Asea Brown Boveri) Neutral UBS AG
12.04.24 Siemens Buy UBS AG
12.04.24 BBVA Overweight JP Morgan Chase & Co.
12.04.24 Santander Buy Goldman Sachs Group Inc.
12.04.24 UBS Buy Goldman Sachs Group Inc.
12.04.24 Deutsche Bank Buy UBS AG
12.04.24 Deutsche Bank Buy Goldman Sachs Group Inc.
12.04.24 BP Overweight Barclays Capital
12.04.24 ING Group Neutral Goldman Sachs Group Inc.
12.04.24 Diageo Sell Deutsche Bank AG
12.04.24 BBVA Sell Goldman Sachs Group Inc.
11.04.24 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
11.04.24 Nokia Neutral UBS AG
11.04.24 Mercedes-Benz Group (ex Daimler) Buy Goldman Sachs Group Inc.
11.04.24 UBS Overweight JP Morgan Chase & Co.
11.04.24 Vodafone Group Buy UBS AG
11.04.24 Deutsche Telekom Buy UBS AG
10.04.24 Vodafone Group Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.04.24 UBS Outperform RBC Capital Markets
10.04.24 Mercedes-Benz Group (ex Daimler) Buy UBS AG
10.04.24 HSBC Neutral JP Morgan Chase & Co.
10.04.24 BBVA Outperform RBC Capital Markets
10.04.24 Novartis Buy UBS AG
10.04.24 Siemens Outperform Bernstein Research
09.04.24 ING Group Buy UBS AG
09.04.24 ING Group Sector Perform RBC Capital Markets
09.04.24 BP Outperform RBC Capital Markets
09.04.24 Rio Tinto Buy Jefferies & Company Inc.
09.04.24 BP Overweight Barclays Capital
09.04.24 HSBC Neutral JP Morgan Chase & Co.
09.04.24 BP Underweight JP Morgan Chase & Co.
09.04.24 HSBC Neutral UBS AG
09.04.24 BP Buy UBS AG
09.04.24 Diageo Hold Jefferies & Company Inc.
09.04.24 BP Buy Jefferies & Company Inc.
09.04.24 BP Underweight JP Morgan Chase & Co.
08.04.24 SAP Overweight Barclays Capital
08.04.24 GSK Equal Weight Barclays Capital
08.04.24 AstraZeneca Overweight Barclays Capital